V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004574 | 280003129 | 1.8 | null | Curative (C) | 2013-07-31 | 2013-08-01 | Trial Unspecified | Y | N | 280027576 | TRIAL |
| 280004575 | 280003130 | null | 104.35 | Adjuvant (A) | 2015-09-12 | 2015-09-13 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | null | 280027587 | NOT MATCHED |
| 280004576 | 280007592 | 1.61 | 51.8 | Curative (C) | 2017-06-10 | 2017-06-10 | Trial Unspecified | N | Y | 280027588 | TRIAL |
| 280004577 | 280003131 | 1.72 | 65.3 | Adjuvant (A) | 2015-01-20 | 2015-01-20 | Trial Unspecified | 02 | Y | 280027591 | TRIAL |
| 280004578 | 280003131 | 1.7 | 62.5 | Curative (C) | 2013-04-10 | 2013-04-10 | Carboplatin + Etoposide iv&po | Y | Y | 280027591 | CARBOPLATIN + ETOPOSIDE |
| 280004579 | 280009874 | 1.58 | 66.8 | null | 2016-03-05 | 2016-03-05 | CARBOPLATIN + RT | N | N | 280027593 | CARBOPLATIN + RT |
| 280004580 | 280010999 | 1.63 | 61.9 | Curative (C) | 2016-04-08 | 2016-04-08 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027594 | CISPLATIN + GEMCITABINE |
| 280004581 | 280010999 | 1.8 | 60 | Palliative (P) | 2014-02-10 | 2014-02-10 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280027594 | CISPLATIN + GEMCITABINE |
| 280004582 | 280003132 | 1.73 | 40 | Curative (C) | null | 2014-07-29 | Trial Unspecified | N | Y | 280027596 | TRIAL |
| 280004583 | 280003132 | 1.7 | 65 | Curative (C) | 2013-12-20 | 2013-12-31 | EOX | 02 | Y | 280027596 | EOX |
| 280004584 | 280003132 | 1.73 | null | Curative (C) | 2013-06-13 | 2013-06-18 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280027596 | CISPLATIN + GEMCITABINE |
| 280004585 | 280003133 | 1.7 | 83.5 | Curative (C) | 2017-07-05 | 2017-07-06 | CISPLATIN + GEMCITABINE | 2 | Y | 280027599 | CISPLATIN + GEMCITABINE |
| 280004586 | 280003133 | 1.6 | 50.6 | Palliative (P) | 2013-11-04 | 2013-11-05 | CARBOPLATIN + RT | N | N | 280027599 | CARBOPLATIN + RT |
| 280004587 | 280003134 | 1.56 | 62.2 | Curative (C) | 2017-05-09 | 2017-05-22 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280027601 | CISPLATIN + GEMCITABINE |
| 280004588 | 280003135 | 1.57 | 10 | Curative (C) | 2015-06-15 | 2015-06-18 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280027602 | CISPLATIN + GEMCITABINE |
| 280004589 | 280003136 | null | 75.2 | Palliative (P) | 2016-07-21 | 2016-08-01 | Olaratumab | N | Y | 280027603 | NOT MATCHED |
| 280004590 | 280007596 | 0 | 82.2 | Curative (C) | 2016-07-05 | 2016-07-06 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 1 | N | 280027606 | NOT MATCHED |
| 280004591 | 280007596 | 1.67 | null | Neo-adjuvant (N) | 2016-09-25 | 2016-09-25 | EOX | 2 | N | 280027606 | EOX |
| 280004592 | 280007596 | 1.62 | 75.1 | Palliative (P) | 2017-05-04 | 2017-05-04 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | null | 280027606 | NOT MATCHED |
| 280004593 | 280003137 | 1.67 | 96 | Curative (C) | null | 2016-02-16 | EOX | N | Y | 280027611 | EOX |
| 280004594 | 280003137 | 1.73 | 74.5 | null | 2016-03-23 | 2016-04-06 | Cetuximab 7 day (Cycle 1) | 2 | Y | 280027611 | CETUXIMAB |
| 280004595 | 280003137 | 1.71 | 100 | Curative (C) | 2017-03-27 | 2017-04-07 | CETUXIMAB | Y | Y | 280027611 | CETUXIMAB |
| 280004596 | 280003137 | 1.74 | 107 | Curative (C) | 2016-08-11 | 2016-09-08 | Carboplatin + Paclitaxel (3 weekly) | Y | N | 280027611 | CARBOPLATIN + PACLITAXEL |
| 280004597 | 280003138 | 1.7 | 70.2 | Curative (C) | 2017-01-16 | 2017-01-16 | Carboplatin AUC 2 - 5 | 02 | N | 280027615 | CARBOPLATIN |
| 280004598 | 280007598 | null | 115.4 | Curative (C) | 2016-08-20 | 2016-08-20 | null | N | N | 280027616 | NOT MATCHED |
| 280004599 | 280007598 | null | 116.8 | Curative (C) | 2017-10-01 | 2017-10-03 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | Y | 280027616 | CISPLATIN + GEMCITABINE |
| 280004600 | 280003139 | null | 45 | Curative (C) | 2016-04-15 | 2016-04-27 | Trial Unspecified | N | Y | 280027619 | TRIAL |
| 280004601 | 280003140 | 1.77 | 12 | Curative (C) | 2014-12-23 | 2014-12-23 | Cisplatin+Gemcitabine (gallbladder) | 02 | Y | 280027622 | CISPLATIN + GEMCITABINE |
| 280004602 | 280007599 | 1.82 | 102.4 | Palliative (P) | null | 2015-12-06 | CARBOPLATIN + RT | Y | null | 280027623 | CARBOPLATIN + RT |
| 280004603 | 280009879 | 1.67 | null | Curative (C) | 2014-09-11 | 2014-09-18 | Carboplatin AUC 2 - 5 | N | N | 280027624 | CARBOPLATIN |
| 280004604 | 280003141 | 0 | 86 | Curative (C) | 2014-09-03 | 2014-09-04 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | Y | 280027627 | NOT MATCHED |
| 280004605 | 280003142 | null | 74.6 | Curative (C) | 2016-09-20 | 2016-10-17 | Carboplatin AUC 2 - 5 | N | N | 280027628 | CARBOPLATIN |
| 280004606 | 280003143 | 1.53 | null | Curative (C) | 2016-04-28 | 2016-05-15 | Carboplatin AUC 2 - 5 | 02 | N | 280027629 | CARBOPLATIN |
| 280004607 | 280003144 | 1.57 | 96 | Palliative (P) | 2016-06-17 | 2016-07-16 | Carboplatin AUC 6 - 10 | 02 | Y | 280027630 | CARBOPLATIN |
| 280004608 | 280003144 | 1.65 | 67 | Curative (C) | 2017-09-26 | 2017-10-14 | CETUXIMAB | Y | N | 280027630 | CETUXIMAB |
| 280004609 | 280003145 | 1.22 | 74 | Curative (C) | 2018-01-18 | 2018-01-19 | Trial Unspecified | N | N | 280027635 | TRIAL |
| 280004610 | 280003146 | 1.62 | 69.1 | Curative (C) | 2015-11-28 | 2015-11-28 | Trial Unspecified | 02 | N | 280027638 | TRIAL |
| 280004611 | 280007601 | 1.61 | 117.6 | Curative (C) | null | 2013-04-28 | Trial Unspecified | N | Y | 280027639 | TRIAL |
| 280004612 | 280007601 | null | 90.7 | Curative (C) | 2017-11-10 | 2017-11-15 | NB Low/Interm risk guidelines CO | 02 | Y | 280027639 | NOT MATCHED |
| 280004613 | 280003147 | null | 72.6 | Adjuvant (A) | 2017-07-25 | 2017-07-31 | Carboplatin AUC 6 - 10 | N | N | 280027643 | CARBOPLATIN |
| 280004614 | 280007602 | null | null | Curative (C) | 2016-01-01 | 2016-01-22 | Cetuximab 7 day (>Cycle 2) | N | N | 280027645 | CETUXIMAB |
| 280004615 | 280003148 | 1.39 | 60.2 | Curative (C) | 2013-06-01 | 2013-06-13 | STS Non-Rhabdo EpSSG 2005 IVA | N | null | 280027646 | NOT MATCHED |
| 280004616 | 280007603 | 1.57 | 59 | Curative (C) | 2015-07-29 | 2015-07-30 | Carboplatin AUC 2 - 5 | 02 | N | 280027649 | CARBOPLATIN |
| 280004617 | 280003149 | 1.74 | 55 | Curative (C) | 2013-05-09 | 2013-05-13 | Carboplatin + Etoposide iv&po | 02 | Y | 280027652 | CARBOPLATIN + ETOPOSIDE |
| 280004618 | 280007604 | 1.64 | 73.9 | Curative (C) | 2014-08-23 | 2014-09-12 | Cetuximab 7 day (Cycle 1) | N | Y | 280027653 | CETUXIMAB |
| 280004619 | 280003150 | 1.53 | 60.4 | Neo-adjuvant (N) | 2014-04-24 | 2014-04-25 | EOX | null | null | 280027655 | EOX |
| 280004620 | 280003150 | 1.66 | 48.2 | Adjuvant (A) | 2015-05-01 | 2015-05-01 | Cisplatin + Gemcitabine (D 1 & 8) | N | Y | 280027655 | CISPLATIN + GEMCITABINE |
| 280004621 | 280003151 | 1.78 | 79.1 | Adjuvant (A) | 2017-06-29 | 2017-07-27 | EW EuroEwing 2012 Arm B VDC | 02 | Y | 280027658 | TRIAL |
| 280004622 | 280003152 | 1.8 | 3 | null | 2017-10-19 | 2017-10-19 | NB HRNBL-1 BUMEL MAT | Y | N | 280027660 | NOT MATCHED |
| 280004623 | 280003152 | 1.84 | 113.9 | Neo-adjuvant (N) | 2017-04-08 | 2017-04-08 | Cetuximab 7 day (Cycle 1) | 02 | N | 280027660 | CETUXIMAB |